Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients.
Baumgartner T, Freyberg M, Campetella L, Crijnen Y, Dargvainiene J, Behning C, Bien CG, Rada A, Prüss H, Rössling R, Kovac S, Strippel C, Thaler FS, Eisenhut K, Lewerenz J, Becker F, Reinecke R, Malter MP, Sühs KW, Tauber SC, Von Podewils F, Melzer N, Wandinger KP, Fernandez Ceballos RA, Kuhle J, Berger K, Bauer T, Rüber T, Racz A, Becker AJ, Pitsch J, Kuhlenbäumer G, Muñiz-Castrillo S, Honnorat J, Titulaer MJ, Leypoldt F, Surges R; and the GENERATE study group.
Baumgartner T, et al. Among authors: behning c.
Neurol Neuroimmunol Neuroinflamm. 2025 Nov;12(6):e200469. doi: 10.1212/NXI.0000000000200469. Epub 2025 Sep 15.
Neurol Neuroimmunol Neuroinflamm. 2025.
PMID: 40953325
Free PMC article.